Compare Salesforce Inc (CRM) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs Recursion Pharmaceuticals Inc — how do they compare? Salesforce Inc trades at $195.24 (market cap $161.73B), while Recursion Pharmaceuticals Inc trades at $3.36 (market cap $1.81B). The key difference: Salesforce Inc is far larger — about 89.4× Recursion Pharmaceuticals Inc's market cap, and Salesforce Inc pays a 0.89% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CRM | RXRX | |
|---|---|---|
Market Cap | $161.73B | $1.81B |
Sector | Technology | Health |
52-Week High | $266.23 | $6.79 |
52-Week Low | $150.12 | $2.84 |
Enterprise Value | $191.77B | $1.33B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $197.51, up 2.47% today, showing strong momentum despite recent sector volatility. The stock demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $3.88 beating expectations of $3.13. Technical indicators show bullish momentum with the price above key support levels, while valuation metrics remain reasonable with P/E of 22.89 and P/S of 4.29. Recent corporate actions include a $0.44 dividend declaration for July 2026 payment.
The outlook remains positive with analyst consensus price target of $230.61 representing 17% upside potential. Strong revenue growth trajectory ($37.9B in 2025 to $42.8B projected for 2026) and expanding profit margins (16.35% to 18.73%) support continued appreciation. Key risks include AI-driven sector volatility and macroeconomic headwinds affecting software spending, but the company's dominant market position and consistent execution provide stability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
